KPC PHARMACEUTICALS,INC KPC Pharmaceuticals,Inc reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 5,610.86 million compared to CNY 6,192.72 million a year ago. Revenue was CNY 5,610.86 million compared to CNY 6,192.72 million a year ago.
Net income was CNY 386.01 million compared to CNY 372.68 million a year ago. Basic earnings per share from continuing operations was CNY 0.51 compared to CNY 0.49 a year ago. Diluted earnings per share from continuing operations was CNY 0.51 compared to CNY 0.49 a year ago.
